Recombinant multi-species RRM2B/p53R2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RRM2B/p53R2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes the small subunit of a p53-inducible ribonucleotide reductase. This heterotetrameric enzyme catalyzes the conversion of ribonucleoside diphosphates to deoxyribonucleoside diphosphates. The product of this reaction is necessary for DNA synthesis. Mutations in this gene have been associated with autosomal recessive mitochondrial DNA depletion syndrome, autosomal dominant progressive external ophthalmoplegia-5, and mitochondrial neurogastrointestinal encephalopathy. Alternatively spliced transcript variants have been described.[provided by RefSeq, Feb 2010]
The Alternative Names of target: MTDPS8A,MTDPS8B,P53R2,RCDFRD,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,Rrm2b,TP53-inducible ribonucleotide reductase M2 B,p53-inducible ribonucleotide reductase small subunit 2-like protein (p53R2),p53R2

Target products collectionGo to RRM2B/p53R2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1559-Ag-1/ GM-Tg-hg-IP1559-Ag-2 Human RRM2B/p53R2 protein Human
GM-Tg-rg-IP1559-Ag-1/ GM-Tg-rg-IP1559-Ag-2 Rat RRM2B/p53R2 protein Rat
GM-Tg-mg-IP1559-Ag-1/ GM-Tg-mg-IP1559-Ag-2 Mouse RRM2B/p53R2 protein Mouse
GM-Tg-cynog-IP1559-Ag-1/ GM-Tg-cynog-IP1559-Ag-2 Cynomolgus/Rhesus macaque RRM2B/p53R2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1559-Ag-1/ GM-Tg-felg-IP1559-Ag-2 Feline RRM2B/p53R2 protein Feline
GM-Tg-cang-IP1559-Ag-1/ GM-Tg-cang-IP1559-Ag-2 Canine RRM2B/p53R2 protein Canine
GM-Tg-bovg-IP1559-Ag-1/ GM-Tg-bovg-IP1559-Ag-2 Bovine RRM2B/p53R2 protein Bovine
GM-Tg-equg-IP1559-Ag-1/ GM-Tg-equg-IP1559-Ag-2 Equine RRM2B/p53R2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1559-Ag-1/ GM-Tg-hg-IP1559-Ag-2; GM-Tg-rg-IP1559-Ag-1/ GM-Tg-rg-IP1559-Ag-2;
GM-Tg-mg-IP1559-Ag-1/ GM-Tg-mg-IP1559-Ag-2; GM-Tg-cynog-IP1559-Ag-1/ GM-Tg-cynog-IP1559-Ag-2;
GM-Tg-felg-IP1559-Ag-1/ GM-Tg-felg-IP1559-Ag-2; GM-Tg-cang-IP1559-Ag-1/ GM-Tg-cang-IP1559-Ag-2;
GM-Tg-bovg-IP1559-Ag-1/ GM-Tg-bovg-IP1559-Ag-2; GM-Tg-equg-IP1559-Ag-1/ GM-Tg-equg-IP1559-Ag-2
Products Name RRM2B/p53R2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RRM2B/p53R2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RRM2B/p53R2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.